Full-Time
Head of Systematic ETF Strategy Team
USA
Trexquant
51-200 employees
Quantitative trading via ML models
Compensation Overview
$130k - $200k/yr
Stamford, CT, USA
In Person
NYC office opening Sep 2026; role currently based in Stamford, CT.
 Finance & Banking (1) |
|---|
- 5+ years of experience researching and trading quantitative ETF-based strategies.
- Bachelor’s, Master’s, or Ph.D. in Mathematics, Statistics, Computer Science, or a related STEM field.
- Proven leadership experience managing quantitative research teams.
- Proficiency in Python.
- Lead and mentor a team of researchers to expand ETF capabilities by identifying new data sources, signals, and strategies.
- Oversee the design, backtesting, and implementation of systematic ETF trading strategies.
- Collaborate with the development team to enhance the performance, robustness, and scalability of ETF simulation and trading infrastructure.
- Partner with execution and financing teams to optimize trade execution and capital efficiency.
- Work with the risk team to establish monitoring frameworks, controls, and capital allocation processes specific to ETF exposures.
- Present ETF research initiatives and progress to senior management, ensuring alignment with firm-wide trading and investment strategies.
- Familiarity with large-scale data analysis and backtesting frameworks.
Trexquant is a quantitative finance firm that builds multi-asset portfolios using machine learning. It develops investment and research tools that ingest a wide range of data variables to create complex trading models and strategies, which in turn generate trading signals. These signals guide decisions across global markets. The product works by applying advanced machine learning to large datasets to create predictive models and rule-based strategies, which drive portfolio construction and trading actions through the firm’s platform. Trexquant differentiates itself by emphasizing the breadth of data it uses and the depth of machine-learning driven models to craft multi-asset portfolios, aiming to produce signals that outperform global market conditions. The company’s goal is to generate investment performance that beats benchmarks by using data-driven signals and diversified, multi-asset strategies.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Stamford, Connecticut
Founded
2012
Simplify's Take
What believers are saying
- Achieved +29.86% total return and +38.76% annualized return, outperforming market benchmarks significantly.
- Expanding into high-growth sectors: fintech, crypto, and health tech via Circle, Galaxy Digital, Hinge Health.
- Tech-heavy allocation (25.99% Computer, 19.13% Electronics) captures AI and semiconductor market tailwinds.
What critics are saying
- Heavy NVDA, PLTR, MSFT concentration exposes portfolio to 20-30% drawdown in tech correction.
- Crypto positions in Circle and Galaxy Digital face regulatory crackdowns and Bitcoin volatility losses.
- Statistical arbitrage underperforms in low-volatility regimes; crowded quant trades squeeze alpha generation.
What makes Trexquant unique
- Machine learning-driven statistical arbitrage generates market-neutral equity strategies across 1,551 global holdings.
- Quantitative platform continuously developed since April 2014 creates proprietary trading signals from vast data variables.
- Portfolio value reached $11.2 billion with diversified exposure across tech, fintech, crypto, and healthcare sectors.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Pre-Tax Commuter Benefits
Performance Bonus
Company News
Trexquant Investment LP bought a new position in The Mosaic Company (NYSE:MOS – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm bought 46,193 shares of the basic materials company’s stock, valued at approximately $1,248,000. Several other institutional investors have also recently made changes to their positions in MOS. NBC Securities Inc. bought a […]
Trexquant Investment LP purchased a new stake in Sinclair in the 4th quarter worth approximately $1,688,000.
Finally, Trexquant Investment LP acquired a new stake in Korro Bio in the fourth quarter worth about $211,000.
Trexquant Investment LP purchased a new stake in Phathom Pharmaceuticals in the 4th quarter worth $3,075,000.
Finally, Trexquant Investment LP purchased a new stake in iShares Core S&P U.S. Growth ETF during the fourth quarter worth approximately $222,000.